246 related articles for article (PubMed ID: 31954521)
1. Identification of a selective DDX3X inhibitor with newly developed quantitative high-throughput RNA helicase assays.
Nakao S; Nogami M; Iwatani M; Imaeda T; Ito M; Tanaka T; Tawada M; Endo S; Cary DR; Ohori M; Imaeda Y; Kawamoto T; Aparicio S; Nakanishi A; Araki S
Biochem Biophys Res Commun; 2020 Mar; 523(3):795-801. PubMed ID: 31954521
[TBL] [Abstract][Full Text] [Related]
2. Discovery of selective ATP-competitive eIF4A3 inhibitors.
Ito M; Iwatani M; Kamada Y; Sogabe S; Nakao S; Tanaka T; Kawamoto T; Aparicio S; Nakanishi A; Imaeda Y
Bioorg Med Chem; 2017 Apr; 25(7):2200-2209. PubMed ID: 28283335
[TBL] [Abstract][Full Text] [Related]
3. Discovery and Characterization of a Eukaryotic Initiation Factor 4A-3-Selective Inhibitor That Suppresses Nonsense-Mediated mRNA Decay.
Iwatani-Yoshihara M; Ito M; Ishibashi Y; Oki H; Tanaka T; Morishita D; Ito T; Kimura H; Imaeda Y; Aparicio S; Nakanishi A; Kawamoto T
ACS Chem Biol; 2017 Jul; 12(7):1760-1768. PubMed ID: 28440616
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel 1,4-Diacylpiperazines as Selective and Cell-Active eIF4A3 Inhibitors.
Ito M; Tanaka T; Cary DR; Iwatani-Yoshihara M; Kamada Y; Kawamoto T; Aparicio S; Nakanishi A; Imaeda Y
J Med Chem; 2017 Apr; 60(8):3335-3351. PubMed ID: 28358513
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formation.
Mazloomian A; Araki S; Ohori M; El-Naggar AM; Yap D; Bashashati A; Nakao S; Sorensen PH; Nakanishi A; Shah S; Aparicio S
Commun Biol; 2019; 2():165. PubMed ID: 31069274
[TBL] [Abstract][Full Text] [Related]
6. Biochemical Differences and Similarities between the DEAD-Box Helicase Orthologs DDX3X and Ded1p.
Sharma D; Putnam AA; Jankowsky E
J Mol Biol; 2017 Nov; 429(23):3730-3742. PubMed ID: 29037760
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Based Screen Links an Inhibitor of Nonsense-Mediated Decay to eIF4A3 Target Engagement.
Cencic R; Naineni SK; Pugsley L; Senéchal P; Sahni A; Pelletier J
ACS Chem Biol; 2020 Jun; 15(6):1621-1629. PubMed ID: 32401488
[TBL] [Abstract][Full Text] [Related]
8. EIF4A3: a gatekeeper of autophagy.
Sakellariou D; Frankel LB
Autophagy; 2021 Dec; 17(12):4504-4505. PubMed ID: 34643458
[TBL] [Abstract][Full Text] [Related]
9. An RNAi screen of RNA helicases identifies eIF4A3 as a regulator of embryonic stem cell identity.
Li D; Yang J; Malik V; Huang Y; Huang X; Zhou H; Wang J
Nucleic Acids Res; 2022 Nov; 50(21):12462-12479. PubMed ID: 36416264
[TBL] [Abstract][Full Text] [Related]
10. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
Shen L; Pelletier J
Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
[TBL] [Abstract][Full Text] [Related]
11. The exon junction complex core factor eIF4A3 is a key regulator of HPV16 gene expression.
Meznad K; Paget-Bailly P; Jacquin E; Peigney A; Aubin F; Guittaut M; Mougin C; Prétet JL; Baguet A
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33760064
[TBL] [Abstract][Full Text] [Related]
12. The Viral Protein K7 Inhibits Biochemical Activities and Condensate Formation by the DEAD-box Helicase DDX3X.
Venus S; Tandjigora K; Jankowsky E
J Mol Biol; 2023 Oct; 435(19):168217. PubMed ID: 37517790
[TBL] [Abstract][Full Text] [Related]
13. The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output.
Kanellis DC; Espinoza JA; Zisi A; Sakkas E; Bartkova J; Katsori AM; Boström J; Dyrskjøt L; Broholm H; Altun M; Elsässer SJ; Lindström MS; Bartek J
Sci Adv; 2021 Aug; 7(32):. PubMed ID: 34348895
[TBL] [Abstract][Full Text] [Related]
14. The eukaryotic initiation factor eIF4H facilitates loop-binding, repetitive RNA unwinding by the eIF4A DEAD-box helicase.
Sun Y; Atas E; Lindqvist L; Sonenberg N; Pelletier J; Meller A
Nucleic Acids Res; 2012 Jul; 40(13):6199-207. PubMed ID: 22457067
[TBL] [Abstract][Full Text] [Related]
15. The DEAD-box helicase eIF4A: paradigm or the odd one out?
Andreou AZ; Klostermeier D
RNA Biol; 2013 Jan; 10(1):19-32. PubMed ID: 22995829
[TBL] [Abstract][Full Text] [Related]
16. Medulloblastoma-associated mutations in the DEAD-box RNA helicase DDX3X/DED1 cause specific defects in translation.
Brown NP; Vergara AM; Whelan AB; Guerra P; Bolger TA
J Biol Chem; 2021; 296():100296. PubMed ID: 33460649
[TBL] [Abstract][Full Text] [Related]
17. Targeting RNA helicases in cancer: The translation trap.
Heerma van Voss MR; van Diest PJ; Raman V
Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):510-520. PubMed ID: 28965870
[TBL] [Abstract][Full Text] [Related]
18. Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors.
Fazi R; Tintori C; Brai A; Botta L; Selvaraj M; Garbelli A; Maga G; Botta M
J Chem Inf Model; 2015 Nov; 55(11):2443-54. PubMed ID: 26544088
[TBL] [Abstract][Full Text] [Related]
19. LINC00667 promotes the proliferation, migration, and pathological angiogenesis in non-small cell lung cancer through stabilizing VEGFA by EIF4A3.
Yang H; Yang W; Dai W; Ma Y; Zhang G
Cell Biol Int; 2020 Aug; 44(8):1671-1680. PubMed ID: 32281700
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated mutants of RNA helicase DDX3X are defective in RNA-stimulated ATP hydrolysis.
Epling LB; Grace CR; Lowe BR; Partridge JF; Enemark EJ
J Mol Biol; 2015 May; 427(9):1779-1796. PubMed ID: 25724843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
